Management of stage I-B, II-A, and II-B carcinoma of the cervix with high-dose-rate brachytherapy: initial results of an institutional clinical trial.

Abitbol, A A; Wolfson, A H; Lewin, A A; Houdek, P V; Laufer, K A; Brandon, A H; Ting, J Y; Raub, W A; Averette, H E; Sevin, B U; Markoe, A M

Abitbol, A A; Wolfson, A H; Lewin, A A; Houdek, P V; Laufer, K A; Brandon, A H; Ting, J Y; Raub, W A; Averette, H E; Sevin, B U; Markoe, A M.

Affiliation

Abitbol AA; Department of Radiation Oncology, Baptist Hospital of Miami, FL 33176, USA.

Am J Clin Oncol ; 19(3): 223-8, 1996 Jun.

Article in En | MEDLINE | ID: mdl-8638529

Subject(s)

Brachytherapy; Uterine Cervical Neoplasms/radiotherapy; Adenocarcinoma/pathology; Adenocarcinoma/radiotherapy; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell/pathology; Carcinoma, Squamous Cell/radiotherapy; Female; Humans; Middle Aged; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms/mortality; Uterine Cervical Neoplasms/pathology

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Brachytherapy / Uterine Cervical Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Am J Clin Oncol Year: 1996 Document type: Article

Search on Google

XML

PubMed Links